NZ749360A - Hydrophobic interaction chromatography for purification of oligonucleotides - Google Patents

Hydrophobic interaction chromatography for purification of oligonucleotides

Info

Publication number
NZ749360A
NZ749360A NZ749360A NZ74936017A NZ749360A NZ 749360 A NZ749360 A NZ 749360A NZ 749360 A NZ749360 A NZ 749360A NZ 74936017 A NZ74936017 A NZ 74936017A NZ 749360 A NZ749360 A NZ 749360A
Authority
NZ
New Zealand
Prior art keywords
oligonucleotides
hydrophobic interaction
purification
interaction chromatography
chromatography
Prior art date
Application number
NZ749360A
Other languages
English (en)
Inventor
Robert Gronke
Ratnesh Joshi
Original Assignee
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Ma Inc filed Critical Biogen Ma Inc
Publication of NZ749360A publication Critical patent/NZ749360A/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/30Partition chromatography
    • B01D15/305Hydrophilic interaction chromatography [HILIC]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32Bonded phase chromatography
    • B01D15/325Reversed phase
    • B01D15/327Reversed phase with hydrophobic interaction
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/42Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424Elution mode
    • B01D15/426Specific type of solvent
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ749360A 2016-06-14 2017-06-13 Hydrophobic interaction chromatography for purification of oligonucleotides NZ749360A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662349970P 2016-06-14 2016-06-14
US201762492402P 2017-05-01 2017-05-01
PCT/US2017/037126 WO2017218454A1 (en) 2016-06-14 2017-06-13 Hydrophobic interaction chromatography for purification of oligonucleotides

Publications (1)

Publication Number Publication Date
NZ749360A true NZ749360A (en) 2025-11-28

Family

ID=59216016

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ749360A NZ749360A (en) 2016-06-14 2017-06-13 Hydrophobic interaction chromatography for purification of oligonucleotides

Country Status (12)

Country Link
US (3) US10947262B2 (enExample)
EP (1) EP3468981B1 (enExample)
JP (1) JP7075359B2 (enExample)
KR (1) KR102461234B1 (enExample)
CN (1) CN109641928B (enExample)
AU (1) AU2017284202B2 (enExample)
BR (1) BR112018075667B1 (enExample)
ES (1) ES2988362T3 (enExample)
IL (1) IL263639B (enExample)
MX (1) MX2018015654A (enExample)
NZ (1) NZ749360A (enExample)
WO (1) WO2017218454A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016040748A1 (en) 2014-09-12 2016-03-17 Ionis Pharmaceuticals, Inc. Compositions and methods for detection of smn protein in a subject and treatment of a subject
TW201628649A (zh) 2014-10-09 2016-08-16 再生元醫藥公司 減少醫藥調配物中微可見顆粒之方法
KR20230041834A (ko) 2016-08-16 2023-03-24 리제너론 파아마슈티컬스, 인크. 혼합물로부터 개별 항체들을 정량하는 방법
CN119492842A (zh) 2016-10-25 2025-02-21 里珍纳龙药品有限公司 用于色谱数据分析的方法和系统
CN118416215A (zh) 2017-09-19 2024-08-02 里珍纳龙药品有限公司 减少粒子形成的方法以及由其形成的组合物
TWI853823B (zh) 2018-07-02 2024-09-01 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
WO2020072062A1 (en) * 2018-10-04 2020-04-09 Gsw Creative Corporation Portable charging case
EP3934620A1 (en) 2019-03-05 2022-01-12 Regeneron Pharmaceuticals, Inc. Human serum albumin in formulations
CN110066789B (zh) * 2019-05-17 2021-04-20 通用生物系统(安徽)有限公司 一种长链dna引物的hplc纯化改进的方法
CN114025805B (zh) * 2019-06-07 2025-01-24 达因疗法公司 制备蛋白质-寡核苷酸复合物的方法
PH12022552258A1 (en) 2020-02-28 2023-11-20 Ionis Pharmaceuticals Inc Compounds and methods for modulating smn2
EP4301766A4 (en) * 2021-03-02 2024-12-25 Ionis Pharmaceuticals, Inc. PURIFICATION PROCESSES FOR OLIGOMERIC COMPOUNDS
CN119855824A (zh) 2022-09-07 2025-04-18 株式会社日本触媒 核酸的制造方法、杂质的去除方法以及杂质少的核酸
CN117050120A (zh) * 2022-12-09 2023-11-14 苏州赛分科技股份有限公司 一种纯化小干扰rna的柱层析法
WO2024175051A1 (zh) * 2023-02-23 2024-08-29 奥安医药(苏州)有限公司 一种疏水层析制备寡核苷酸的方法
WO2025149349A1 (en) 2024-01-09 2025-07-17 Cytiva Bioprocess R&D Ab Method for separating nucleic acid molecules
WO2025234897A1 (ru) * 2024-05-07 2025-11-13 Акционерное общество "ГЕНЕРИУМ" Способ получения тиофосфатных олигонуклеотидов для терапевтического применения

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60104097A (ja) * 1983-11-08 1985-06-08 Sagami Chem Res Center Dνaの精製方法
DE3433649A1 (de) * 1984-09-13 1986-03-20 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Verfahren zur aufreinigung synthetischer oligonucleotide
US6087491A (en) * 1993-01-08 2000-07-11 Hybridon, Inc. Extremely high purity oligonucleotides and methods of synthesizing them using dimer blocks
AU2952395A (en) 1994-07-05 1996-01-25 Hybridon, Inc. Purification of oligodeoxynucleotide phosphorothioates using deae 5pw anion ion-exchange chromatography and hydrophobic interaction chromatography
CN1155887A (zh) * 1994-07-05 1997-07-30 海布里顿公司 用deae-5pw阴离子-离子交换色谱和疏水作用色谱纯化硫代磷酸寡脱氧核苷酸
EP0979233A4 (en) * 1997-04-21 2001-03-21 Proligo L L C Method for solution phase synthesis of oligonucleotides
JP2000035423A (ja) 1998-05-11 2000-02-02 Tosoh Corp 液体クロマトグラフィ―による核酸の分離法
CA2375215C (en) * 1999-05-28 2012-11-20 Bio Science Contract Production Corporation Methods of dna purification and purified dna
PT102491B (pt) * 2000-07-10 2003-02-28 Inst Superior Tecnico Processo para producao e purificacao de dna plasmidico
US7345163B2 (en) * 2002-08-28 2008-03-18 Quiatech Ab Process for separating and deprotecting oligonucleotides
WO2004041889A2 (en) 2002-11-05 2004-05-21 Isis Pharmaceuticals, Inc. Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
US20050019951A1 (en) * 2003-07-14 2005-01-27 Gjerde Douglas T. Method and device for extracting an analyte
EP1661905B9 (en) 2003-08-28 2012-12-19 IMANISHI, Takeshi Novel artificial nucleic acids of n-o bond crosslinkage type
BRPI0509490A (pt) * 2004-04-19 2007-09-11 Centelion método de purificação de plasmìdeo dna
ES2397113T3 (es) 2005-06-23 2013-03-04 Isis Pharmaceuticals, Inc. Composiciones y procedimientos para modular el corte y empalme de SMN2
ES2351674T3 (es) 2006-01-27 2011-02-09 Isis Pharmaceuticals, Inc. Análogos de ácidos nucleicos bicíclicos modificados en la posición 6.
US8969068B2 (en) * 2008-04-30 2015-03-03 Gradalis, Inc. Processes for the preparation of highly pure plasmid compositions by enzymatic digestion of colanic acid
CN115227709A (zh) 2009-06-17 2022-10-25 冷泉港实验室 用于在对象中调节smn2剪接的组合物和方法
MY192634A (en) 2014-04-01 2022-08-29 Biogen Ma Inc Compositions for modulating sod-1 expression

Also Published As

Publication number Publication date
MX2018015654A (es) 2019-06-10
BR112018075667B1 (pt) 2024-02-20
AU2017284202A1 (en) 2019-01-17
JP7075359B2 (ja) 2022-05-25
JP2019518759A (ja) 2019-07-04
CA3027288A1 (en) 2017-12-21
US10947262B2 (en) 2021-03-16
US20190248823A1 (en) 2019-08-15
KR102461234B1 (ko) 2022-10-28
CN109641928A (zh) 2019-04-16
ES2988362T3 (es) 2024-11-20
US20250011357A1 (en) 2025-01-09
BR112018075667A2 (pt) 2019-04-09
IL263639A (en) 2019-01-31
EP3468981A1 (en) 2019-04-17
KR20190018467A (ko) 2019-02-22
IL263639B (en) 2021-09-30
CN109641928B (zh) 2022-08-30
US20210269467A1 (en) 2021-09-02
EP3468981B1 (en) 2024-07-24
AU2017284202B2 (en) 2021-11-04
WO2017218454A1 (en) 2017-12-21

Similar Documents

Publication Publication Date Title
MX2018015654A (es) Cromatografía de interacción hidrofóbica para la purificación de oligonucleótidos.
HUE068564T2 (hu) Multispecifikus antitestek tisztítása
ZA201706944B (en) Process for the purification of water
CL2016002157A1 (es) Anticuerpos anti-cd38 para el tratamiento de leucemia linfoide aguda
EA202092609A1 (ru) Антитела к cd38 для лечения острого миелолейкоза
MY191884A (en) Oil purification process
MX2019011554A (es) Purificacion de ficobiliproteinas.
PT3655138T (pt) Processo para a purificação de ácido hialurónico
MX381562B (es) Proceso para aislar y purificar ambrox.
ZA201903408B (en) Process for purification of pyrazolpyridazines
HUE060530T2 (hu) Eljárás halonitroaromás vegyületek katalitikus hidrogénezésére
PL3564250T3 (pl) Sposób oczyszczania alulozowego produktu reakcji konwersji
SI3347481T1 (sl) Proces za čiščenje hidrolizata biomase
EP3318552A4 (en) PROCESS FOR CLEANING METHIONINE
EP3508493A4 (en) PROTEIN PURIFICATION PROCESS WITH ACTIVE CARBON
FR3021230B1 (fr) Procede de purification de nanofils metalliques
MX2017012342A (es) Compuestos biciclicos fusionados para el tratamiento de enfermedades,.
HUE063127T2 (hu) Eljárás metilkobalamin tisztítására
EP3404037A4 (en) PROCESS FOR CLEANING FIBRINOGEN
EP3393983A4 (en) METHOD FOR INCREASING THE WATERPROOFABILITY OF ENTIRE TREATMENTS
SG11201802755WA (en) Process for purification of methyl methacrylate
MX2019002017A (es) Derivados de sofosbuvir para el tratamiento de la hepatitis c.
PL3497054T3 (pl) Sposób oczyszczania fosforu żółtego
MX2020010343A (es) Proceso para la purificacion de biocomposiciones complejas.
HUP1500502A2 (en) Process for the purification of cyclosporin-a

Legal Events

Date Code Title Description
PSEA Patent sealed